Verified Nov 2026
Electronics & Software
·

Rome, Lazio
·
Since
MSD Italia is a biopharmaceutical subsidiary of Merck & Co. headquartered in Rome, founded in 1956. The company employs 1,000–5,000 staff and generates approximately 700 million euros in revenue. It develops and manufactures human medicines targeting cardiovascular disease, diabetes, oncology, and immunology; produces vaccines for human and animal health; and operates digital health and clinical research services across Italy.
MSD Italia at a glance
Revenue
$500M-1B
Est. band
Employees
1,000-5,000
Headquarters
Rome, Lazio
Certifications
ISO 9001
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
Overview
MSD Italia is a biopharmaceutical subsidiary of Merck & Co. headquartered in Rome, founded in 1956. The company employs 1,000–5,000 staff and generates approximately 700 million euros in revenue. It develops and manufactures human medicines targeting cardiovascular disease, diabetes, oncology, and immunology; produces vaccines for human and animal health; and operates digital health and clinical research services across Italy.
At a glance
Attribute | Detail |
|---|---|
Headquarters | Rome, Lazio |
Employees | 1,000-5,000 |
Revenue | $500M-1B (estimated) |
Primary capability | Electronics & Software |
Certifications | ISO 9001 |
What MSD Italia makes
MSD Italia holds ISO 9001 certification and develops a portfolio exceeding 200 human medicines alongside vaccine manufacturing for both human and veterinary markets.
Certifications
MSD Italia is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 9001 — dailyhealthindustry.it
Latest developments
2026-10-27 — FARMACO ENFLONSIA, vinta da MSD ITALIA S.R.L. | Polyfacto Tender (polyfacto.com)
2026-10-22 — Fornitura Vaxneuvance*IM 1 siringa 0,5 ml + 2 aghi — gara d'appalto in Italia | El Vínculo (el-vinculo.com)
2026-06-23 — Vaccines Europe Welcomes New Leadership Team - Vaccines Europe (vaccineseurope.eu)
2026-06-19 — Notizie Archives - MSD Italia (msd-italia.it)
2026-04-01 — Prange Pharma completa l'acquisizione del sito Msd Animal Health di Aprilia - AboutPharma (aboutpharma.com)
2025-11-21 — Msd rafforza l’impegno nella salute pubblica e diventa premium partner della Serie A Women (forbes.it)
Company details
As a Merck & Co. subsidiary, the company serves healthcare institutions and public health programs across Italy's pharmaceutical and veterinary sectors. MSD Italia has an estimated 1,000-5,000 employees, and is headquartered in Rome, Lazio.
Frequently asked questions
What does MSD Italia make?
MSD Italia is a biopharmaceutical subsidiary of Merck & Co. headquartered in Rome, founded in 1956. The company employs 1,000–5,000 staff and generates approximately 700 million euros in revenue. It develops and manufactures human medicines targeting cardiovascular disease, diabetes, oncology, and immunology; produces vaccines for human and animal health; and operates digital health and clinical research services across Italy.
Where is MSD Italia headquartered?
MSD Italia is headquartered in Rome, Lazio (151 Via Vitorchiano, Rome, Lazio, 00189).
How big is MSD Italia?
MSD Italia has an estimated 1,000-5,000 employees, with revenue in the $500M-1B range (estimated).
What certifications does MSD Italia hold?
MSD Italia lists ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
